These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 7507253)

  • 61. Major histocompatibility complex-controlled protective influences on experimental autoimmune encephalomyelitis are peptide specific.
    Issazadeh S; Kjellén P; Olsson T; Mustafa M; Holmdahl R
    Eur J Immunol; 1997 Jun; 27(6):1584-7. PubMed ID: 9209515
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Presentation of a determinant by MHC class II can be prevented through competitive capture by a flanking determinant on a multideterminant peptide.
    Maverakis E; Beech JT; Schneider S; Sercarz EE
    J Autoimmun; 2008 Aug; 31(1):59-65. PubMed ID: 18375101
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Human myelin basic protein (MBP) epitopes recognized by mouse MBP-selected T cell lines from multiple sclerosis patients.
    Chou YK; Jones RE; Bourdette D; Whitham R; Hashim G; Atherton J; Offner H; Vandenbark AA
    J Neuroimmunol; 1994 Jan; 49(1-2):45-50. PubMed ID: 7507496
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Influence of the H-2u haplotype on immune function in F1 hybrid mice. I. Antigen presentation.
    Fritz RB; Skeen MJ; Ziegler HK
    J Immunol; 1985 Jun; 134(6):3574-9. PubMed ID: 2580890
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Two-domain MHC class II molecules form stable complexes with myelin basic protein 69-89 peptide that detect and inhibit rat encephalitogenic T cells and treat experimental autoimmune encephalomyelitis.
    Burrows GG; Bebo BF; Adlard KL; Vandenbark AA; Offner H
    J Immunol; 1998 Dec; 161(11):5987-96. PubMed ID: 9834080
    [TBL] [Abstract][Full Text] [Related]  

  • 66. HLA-DR-restricted presentation of purified myelin basic protein is independent of intracellular processing.
    Vergelli M; Pinet V; Vogt AB; Kalbus M; Malnati M; Riccio P; Long EO; Martin R
    Eur J Immunol; 1997 Apr; 27(4):941-51. PubMed ID: 9130648
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Identification of a second mimicry epitope from Acanthamoeba castellanii that induces CNS autoimmunity by generating cross-reactive T cells for MBP 89-101 in SJL mice.
    Massilamany C; Asojo OA; Gangaplara A; Steffen D; Reddy J
    Int Immunol; 2011 Dec; 23(12):729-39. PubMed ID: 22058327
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Myelin basic protein peptide complexes with the class II MHC molecules I-Au and I-Ak form and dissociate rapidly at neutral pH.
    Mason K; Denney DW; McConnell HM
    J Immunol; 1995 May; 154(10):5216-27. PubMed ID: 7537302
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Alterations in T cell antigen specificity and class II restriction during the course of chronic relapsing experimental allergic encephalomyelitis.
    McCarron RM; Fallis RJ; McFarlin DE
    J Neuroimmunol; 1990; 29(1-3):73-9. PubMed ID: 1698817
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Active immunization with complementary peptide PBM 9-1: preliminary evidence that it modulates experimental allergic encephalomyelitis in PL/J mice and Lewis rats.
    Zhou SR; Whitaker JN
    J Neurosci Res; 1996 Aug; 45(4):439-46. PubMed ID: 8872904
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Anergy induction in encephalitogenic T cells by brain microvessel endothelial cells is inhibited by interleukin-1.
    Bourdoulous S; Béraud E; Le Page C; Zamora A; Ferry A; Bernard D; Strosberg AD; Couraud PO
    Eur J Immunol; 1995 May; 25(5):1176-83. PubMed ID: 7539749
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Expansion by self antigen is necessary for the induction of experimental autoimmune encephalomyelitis by T cells primed with a cross-reactive environmental antigen.
    Carrizosa AM; Nicholson LB; Farzan M; Southwood S; Sette A; Sobel RA; Kuchroo VK
    J Immunol; 1998 Oct; 161(7):3307-14. PubMed ID: 9759846
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Specific treatment of autoimmunity with recombinant invariant chains in which CLIP is replaced by self-epitopes.
    Bischof F; Wienhold W; Wirblich C; Malcherek G; Zevering O; Kruisbeek AM; Melms A
    Proc Natl Acad Sci U S A; 2001 Oct; 98(21):12168-73. PubMed ID: 11593032
    [TBL] [Abstract][Full Text] [Related]  

  • 74. HLA class II peptide-binding and autoimmunity.
    Gebe JA; Swanson E; Kwok WW
    Tissue Antigens; 2002 Feb; 59(2):78-87. PubMed ID: 12028533
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Immunodominant framework region 3 peptide from TCR V beta 8.2 chain controls murine experimental autoimmune encephalomyelitis.
    Kumar V; Tabibiazar R; Geysen HM; Sercarz E
    J Immunol; 1995 Feb; 154(4):1941-50. PubMed ID: 7530748
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Inhibition of experimental autoimmune encephalomyelitis by a nonimmunogenic non-self peptide that binds to I-Au.
    Gautam AM; Pearson CI; Sinha AA; Smilek DE; Steinman L; McDevitt HO
    J Immunol; 1992 May; 148(10):3049-54. PubMed ID: 1578131
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Biological activity of recombinant human myelin basic protein.
    Oettinger HF; al-Sabbagh A; Jingwu Z; LaSalle JM; Weiner HL; Hafler DA
    J Neuroimmunol; 1993 May; 44(2):157-62. PubMed ID: 7685037
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A small number of residues in the class II molecule I-Au confer the ability to bind the myelin basic protein peptide Ac1-11.
    Pearson CI; Gautam AM; Rulifson IC; Liblau RS; McDevitt HO
    Proc Natl Acad Sci U S A; 1999 Jan; 96(1):197-202. PubMed ID: 9874795
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Affinity for class II MHC determines the extent to which soluble peptides tolerize autoreactive T cells in naive and primed adult mice--implications for autoimmunity.
    Liu GY; Wraith DC
    Int Immunol; 1995 Aug; 7(8):1255-63. PubMed ID: 7495732
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Rat RT1.B-transfected fibroblast lines process and present myelin antigens and activate T cells to induce experimental autoimmune encephalomyelitis.
    Buenafe AC; Tsu RC; McMahan R; Bebo BF; Vandenbark AA; Offner H
    J Neuroimmunol; 2001 Jan; 112(1-2):106-14. PubMed ID: 11108939
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.